Werewolf Therapeutics

HOWLNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$47.724 M

$0.98 +0.20%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$60.8M

Loss-making

Shares outstanding

48,599,066

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#356Mereo BioPharma GroupMREO$49.1M
#357ScynexisSCYX$48.4M
#358Werewolf TherapeuticsHOWL$47.7M
#359Grace TherapeuticsGRCE$45.0M
#360VeruVERU$42.6M

What if Werewolf Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$622,110.10

Per share 633,513× higher

Bitcoin $1.74T

$35,837.21

Per share 36,494× higher

Nvidia $5.52T

$113,495.33

Per share 115,576× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Werewolf Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.